“National Immunobiological Company” is a pharmaceutical holding created by the Rostec state corporation in 2013 with the aim of developing the production of immunobiological drugs important for national security. The holding unites Russian pharmaceutical enterprises — NPO Microgen and the biopharmaceutical company FORT (10 production facility). The scope of Nacimbio activities includes the development, full-cycle production and realization of vaccines and toxoids of the current and future National Calendar of Preventive Vaccinations, blood products, bacteriophages, allergens, allergoids and other drugs. The holding’s product portfolio includes more than 220 types of medicines.